Cancer Epidemiology Biomarkers & Prevention, Vol 4, Issue 4 313-318, Copyright © 1995 by American Association for Cancer Research

ARTICLES

Synergistic effect between alcohol and estrogen replacement therapy on risk of breast cancer differs by estrogen/progesterone receptor status in the Iowa Women's Health Study

SM Gapstur, JD Potter, C Drinkard and AR Folsom
Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis 55454-1015, USA.

Two cohort studies have reported that alcohol and estrogen replacement therapy (ERT) act synergistically to increase the incidence of breast cancer. Possible interactions between alcohol consumption and family history of breast cancer or body mass index were also reported in the Iowa Women's Health Study data. In the Iowa Women's Health Study cohort, alcohol appears to be associated only with estrogen receptor-negative (ER-)/progesterone receptor-negative (PR-) breast cancers. Therefore, we investigated whether the interactions between alcohol and other risk factors differ according to ER/PR status. In January 1986, participants completed a questionnaire that included alcohol intake and other information. Through 1992, 939 breast cancer cases occurred among 37,105 postmenopausal women at risk. Cox proportional hazards regression was used to compute adjusted relative risks and to test for multiplicative interactions. Relative risks of ER+/PR+, ER+/PR-, and ER-/PR- breast cancer for women who consumed > or = 4.0 g of ethanol/day and reported ever using ERT compared to abstainers who never used ERT were 1.8, 1.3, and 2.6, respectively. Relative risks of ER+/PR+, ER+/PR-, and ER-/PR- breast cancer associated with any alcohol intake and a positive family history of breast cancer compared to abstainers with no family history of breast cancer were 1.7, 0.8, and 3.1, respectively. Relative risks of ER+/PR+, ER+/PR-, and ER-/PR- breast cancer associated with the highest quintile of body mass index and drinking > or = 4.0 g of ethanol/day compared to abstainers in the lower four-fifths of body mass index were 0.9, 1.8, and 2.0, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				K. Ishitani, J. Lin, J. E. Manson, J. E. Buring, and S. M. Zhang A Prospective Study of Multivitamin Supplement Use and Risk of Breast Cancer Am. J. Epidemiol., May 15, 2008; 167(10): 1197 - 1206. [Abstract] [Full Text] [PDF]

				S. M. Zhang, I-M. Lee, J. E. Manson, N. R. Cook, W. C. Willett, and J. E. Buring Alcohol Consumption and Breast Cancer Risk in the Women's Health Study Am. J. Epidemiol., March 15, 2007; 165(6): 667 - 676. [Abstract] [Full Text] [PDF]

				A. Bardia, L. C. Hartmann, C. M. Vachon, R. A. Vierkant, A. H. Wang, J. E. Olson, T. A. Sellers, and J. R. Cerhan Recreational Physical Activity and Risk of Postmenopausal Breast Cancer Based on Hormone Receptor Status Arch Intern Med, December 11, 2006; 166(22): 2478 - 2483. [Abstract] [Full Text] [PDF]

				L. U. Rosenberg, K. Einarsdottir, E. I. Friman, S. Wedren, P. W. Dickman, P. Hall, and C. Magnusson Risk Factors for Hormone Receptor-Defined Breast Cancer in Postmenopausal Women Cancer Epidemiol. Biomarkers Prev., December 1, 2006; 15(12): 2482 - 2488. [Abstract] [Full Text] [PDF]

				R. Suzuki, W. Ye, T. Rylander-Rudqvist, S. Saji, G. A. Colditz, and A. Wolk Alcohol and Postmenopausal Breast Cancer Risk Defined by Estrogen and Progesterone Receptor Status: A Prospective Cohort Study J Natl Cancer Inst, November 2, 2005; 97(21): 1601 - 1608. [Abstract] [Full Text] [PDF]

				S. R. Gorla, N. Hou, S. Acharya, A. Rademaker, S. Khan, V. Staradub, and M. Morrow A Predictive Model for the Development of Hormone-Responsive Breast Cancer Ann. Surg. Oncol., January 1, 2005; 12(1): 48 - 56. [Abstract] [Full Text] [PDF]

				J. A. McDonald, M. G. Mandel, P. A. Marchbanks, S. G. Folger, J. R. Daling, G. Ursin, M. S. Simon, L. Bernstein, B. L. Strom, S. A. Norman, et al. Alcohol Exposure and Breast Cancer: Results of the Women's Contraceptive and Reproductive Experiences Study Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2106 - 2116. [Abstract] [Full Text] [PDF]

				M. D. Althuis, J. H. Fergenbaum, M. Garcia-Closas, L. A. Brinton, M. P. Madigan, and M. E. Sherman Etiology of Hormone Receptor-Defined Breast Cancer: A Systematic Review of the Literature Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1558 - 1568. [Abstract] [Full Text] [PDF]

				M. J. Borugian, S. B. Sheps, C. Kim-Sing, C. Van Patten, J. D. Potter, B. Dunn, R. P. Gallagher, and T. G. Hislop Insulin, Macronutrient Intake, and Physical Activity: Are Potential Indicators of Insulin Resistance Associated with Mortality from Breast Cancer? Cancer Epidemiol. Biomarkers Prev., July 1, 2004; 13(7): 1163 - 1172. [Abstract] [Full Text] [PDF]

				C. I. Li, K. E. Malone, P. L. Porter, N. S. Weiss, M.-T. C. Tang, and J. R. Daling The Relationship between Alcohol Use and Risk of Breast Cancer by Histology and Hormone Receptor Status among Women 65-79 Years of Age Cancer Epidemiol. Biomarkers Prev., October 1, 2003; 12(10): 1061 - 1066. [Abstract] [Full Text] [PDF]

				K. W. Singletary and S. M. Gapstur Alcohol and Breast Cancer: Review of Epidemiologic and Experimental Evidence and Potential Mechanisms JAMA, November 7, 2001; 286(17): 2143 - 2151. [Abstract] [Full Text] [PDF]

				R. C. Ellison, Y. Zhang, C. E. McLennan, and K. J. Rothman Exploring the Relation of Alcohol Consumption to Risk of Breast Cancer Am. J. Epidemiol., October 15, 2001; 154(8): 740 - 747. [Abstract] [Full Text] [PDF]

				S. Fan, Q. Meng, B. Gao, J. Grossman, M. Yadegari, I. D. Goldberg, and E. M. Rosen Alcohol Stimulates Estrogen Receptor Signaling in Human Breast Cancer Cell Lines Cancer Res., October 1, 2000; 60(20): 5635 - 5639. [Abstract] [Full Text]